BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22084190)

  • 41. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)].
    Kusaba H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [RECIST and the radiologist].
    Cervera Deval J
    Radiologia; 2014; 56(3):193-205. PubMed ID: 22902252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor Response Evaluation Criteria: Standardization Ensures Success.
    Zaman MU; Fatima N; Sajid M
    J Coll Physicians Surg Pak; 2017 Jul; 27(7):389-391. PubMed ID: 28818157
    [No Abstract]   [Full Text] [Related]  

  • 44. The American Board of Radiology perspective on maintenance of certification: part IV--practice quality improvement in diagnostic radiology.
    Strife JL; Kun LE; Becker GJ; Dunnick NR; Bosma J; Hattery RR
    J Am Coll Radiol; 2007 May; 4(5):300-4. PubMed ID: 17467612
    [No Abstract]   [Full Text] [Related]  

  • 45. ACR Appropriateness Criteria on low back pain.
    Davis PC; Wippold FJ; Brunberg JA; Cornelius RS; De La Paz RL; Dormont PD; Gray L; Jordan JE; Mukherji SK; Seidenwurm DJ; Turski PA; Zimmerman RD; Sloan MA
    J Am Coll Radiol; 2009 Jun; 6(6):401-7. PubMed ID: 19467485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstrating the value of imaging to patients' health.
    Hillman BJ
    J Am Coll Radiol; 2009 Aug; 6(8):543. PubMed ID: 19643378
    [No Abstract]   [Full Text] [Related]  

  • 47. American Board of Radiology Perspective on Maintenance of Certification: Part IV--Practice Quality Improvement for Diagnostic Radiology.
    Strife JL; Kun LE; Becker GJ; Dunnick NR; Bosma J; Hattery RR
    Radiographics; 2007; 27(3):769-74. PubMed ID: 17495291
    [No Abstract]   [Full Text] [Related]  

  • 48. Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy.
    Hittinger M; Staehler M; Schramm N; Ubleis C; Becker C; Reiser M; Berger F
    Urol Oncol; 2012 Sep; 30(5):695-703. PubMed ID: 21865061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance quality improvement projects: suggestions for radiologists who image children.
    Safdar N; Rubio EI; Nagy P
    J Am Coll Radiol; 2011 Dec; 8(12):875-7. PubMed ID: 22137007
    [No Abstract]   [Full Text] [Related]  

  • 50. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.
    Herrmann K; Benz MR; Krause BJ; Pomykala KL; Buck AK; Czernin J
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):620-32. PubMed ID: 22231582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peer review in diagnostic radiology: current state and a vision for the future.
    Mahgerefteh S; Kruskal JB; Yam CS; Blachar A; Sosna J
    Radiographics; 2009; 29(5):1221-31. PubMed ID: 19564252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of radiologists in reducing diagnostic error in health care.
    Allen B
    J Am Coll Radiol; 2014 Dec; 11(12 Pt A):1101-2. PubMed ID: 25467720
    [No Abstract]   [Full Text] [Related]  

  • 53. In support of the ACR Appropriateness Criteria.
    Sistrom CL;
    J Am Coll Radiol; 2008 May; 5(5):630-5; discussion 636-7. PubMed ID: 18442767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the response to therapy of neoplastic lesions.
    Bellomi M; Preda L
    Radiol Med; 2004; 107(5-6):450-8. PubMed ID: 15195007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond.
    Nishino M
    Am Soc Clin Oncol Educ Book; 2018 May; 38():1019-1029. PubMed ID: 30231378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance.
    Eberhardt SC; Carter S; Casalino DD; Merrick G; Frank SJ; Gottschalk AR; Leyendecker JR; Nguyen PL; Oto A; Porter C; Remer EM; Rosenthal SA
    J Am Coll Radiol; 2013 Feb; 10(2):83-92. PubMed ID: 23374687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The future quality and safety of medical imaging: proceedings of the third annual ACR FORUM.
    Hillman BJ; Amis ES; Neiman HL;
    J Am Coll Radiol; 2004 Jan; 1(1):33-9. PubMed ID: 17411517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on criteria for assessing tumor response to treatment.
    Cruite I; Osman S; Dighe M
    Curr Probl Diagn Radiol; 2013; 42(5):209-19. PubMed ID: 24070714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cancer treatment response evaluation based on imaging modalities, such as computed tomography, magnetic resonance imaging and FDG-PET].
    Endo M; Aramaki T; Moriguchi M; Sawada A; Asakura K; Bekku E
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):294-8. PubMed ID: 23507590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACR Appropriateness Criteria® chronic chest pain--high probability of coronary artery disease.
    Earls JP; White RD; Woodard PK; Abbara S; Atalay MK; Carr JJ; Haramati LB; Hendel RC; Ho VB; Hoffman U; Khan AR; Mammen L; Martin ET; Rozenshtein A; Ryan T; Schoepf J; Steiner RM; White CS
    J Am Coll Radiol; 2011 Oct; 8(10):679-86. PubMed ID: 21962781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.